Latest news
Can AXPAXLI serve as a foundational therapy to improve durability in wet AMD? - Ophthalmology Times EuropeOphthalmology Times Europe · Sun, 09 Aug 2026 13:05:37 GMTDermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - Eagle-TribuneEagle-Tribune · Wed, 05 Aug 2026 12:31:47 GMTDermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - NasdaqNasdaq · Wed, 05 Aug 2026 12:30:00 GMTDermata's planned $178 skincare set includes four weekly treatments - Stock TitanStock Titan · Wed, 05 Aug 2026 12:30:00 GMTDermata’s First Consumer Brand Wants to Function as ‘Microneedling Lite’ - WWDWWD · Wed, 05 Aug 2026 04:03:11 GMT